Post-SVR Fibrosis Regression — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Continue hepatocellular-carcinoma surveillance after virological cure
The best answer is “Continue hepatocellular-carcinoma surveillance after virological cure”. Viral cure improves fibrosis and clinical outcomes, but established cirrhosis does not uniformly reverse and residual HCC risk remains clinically important. Sustained virological response markedly reduces liver events and can permit fibrosis regression, but patients with established cirrhosis retain hepatocellular-carcinoma risk and need surveillance.
Reference: EASL recommendations on treatment of hepatitis C: https://easl.eu/publication/easl-recommendations-on-treatment-of-hepatitis-c/